87 related articles for article (PubMed ID: 21292490)
1. Predictive factors for early symptomatic recurrence in pilocytic astrocytoma: does angiogenesis have a role to play?
Kurwale NS; Suri V; Suri A; Sarkar C; Gupta DK; Sharma BS; Mahapatra AK
J Clin Neurosci; 2011 Apr; 18(4):472-7. PubMed ID: 21292490
[TBL] [Abstract][Full Text] [Related]
2. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
3. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
[TBL] [Abstract][Full Text] [Related]
4. [p53 and vascular endothelial growth factor expression in astrocytoma and their relation to angiogenesis].
Ye S; Zhong X; Chen Y
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):326-9. PubMed ID: 11783119
[TBL] [Abstract][Full Text] [Related]
5. Postoperative imaging surveillance in pediatric pilocytic astrocytomas.
Dorward IG; Luo J; Perry A; Gutmann DH; Mansur DB; Rubin JB; Leonard JR
J Neurosurg Pediatr; 2010 Oct; 6(4):346-52. PubMed ID: 20887107
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of pilomyxoid astrocytomas: intermediate pilomyxoid tumors.
Johnson MW; Eberhart CG; Perry A; Tihan T; Cohen KJ; Rosenblum MK; Rais-Bahrami S; Goldthwaite P; Burger PC
Am J Surg Pathol; 2010 Dec; 34(12):1783-91. PubMed ID: 21107083
[TBL] [Abstract][Full Text] [Related]
7. Pilocytic astrocytoma: a retrospective study of 32 cases.
Cyrine S; Sonia Z; Mounir T; Badderedine S; Kalthoum T; Hedi K; Moncef M
Clin Neurol Neurosurg; 2013 Aug; 115(8):1220-5. PubMed ID: 23265563
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor and basic fibroblast growth factor expression positively correlates with angiogenesis and peritumoural brain oedema in astrocytoma.
Jang FF; Wei W; De WM
J Ayub Med Coll Abbottabad; 2008; 20(2):105-9. PubMed ID: 19385471
[TBL] [Abstract][Full Text] [Related]
9. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in association with neovascularization in human primary astrocytoma.
Pan JW; Zhan RY; Tong Y; Zhou YQ; Zhang M
J Zhejiang Univ Sci B; 2005 Jul; 6(7):693-8. PubMed ID: 15973775
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management.
Emamaullee JA; Edgar R; Toso C; Thiesen A; Bain V; Bigam D; Kneteman N; Shapiro AM
Liver Transpl; 2010 Feb; 16(2):191-7. PubMed ID: 20104492
[TBL] [Abstract][Full Text] [Related]
11. Histopathologic predictors of pilocytic astrocytoma event-free survival.
Tibbetts KM; Emnett RJ; Gao F; Perry A; Gutmann DH; Leonard JR
Acta Neuropathol; 2009 Jun; 117(6):657-65. PubMed ID: 19271226
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
Machen SK; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological feature of pilomyxoid astrocytomas: three case reports.
Nagaishi M; Yokoo H; Hirato J; Yoshimoto Y; Nakazato Y
Neuropathology; 2011 Apr; 31(2):152-7. PubMed ID: 20667008
[TBL] [Abstract][Full Text] [Related]
15. Differences in vasculature between pilocytic and anaplastic astrocytomas of childhood.
Gesundheit B; Klement G; Senger C; Kerbel R; Kieran M; Baruchel S; Becker L
Med Pediatr Oncol; 2003 Dec; 41(6):516-26. PubMed ID: 14595708
[TBL] [Abstract][Full Text] [Related]
16. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
17. Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence.
Sidle DM; Maddalozzo J; Meier JD; Cornwell M; Stellmach V; Crawford SE
Arch Otolaryngol Head Neck Surg; 2005 Nov; 131(11):990-5. PubMed ID: 16301371
[TBL] [Abstract][Full Text] [Related]
18. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease.
Fukuda S; Shirahama T; Imazono Y; Tsushima T; Ohmori H; Kayajima T; Take S; Nishiyama K; Yonezawa S; Akiba S; Akiyama S; Ohi Y
Cancer; 1999 Mar; 85(6):1323-30. PubMed ID: 10189138
[TBL] [Abstract][Full Text] [Related]
19. Diversity of glial cell components in pilocytic astrocytoma.
Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]